Abstract
Condition: Multiple Sclerosis
Intervention: Drug: Ocrelizumab
Sponsors: NYU Langone Health; Genentech, Inc.
Recruiting
ID: 51
Discovery Date: 22 April 2021, 20:19:01 UTC
Published Date: 2021-04-22 16:00:00
Source: Clinical Trials.gov
Link: https://clinicaltrials.gov/ct2/show/NCT04855617?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14